Quick Takeaways:
- Parnell has launched a 50 mL presentation of PropofolVet Multidose, its first generic propofol injectable emulsion for dogs, alongside the existing 20 mL option. The new size is designed to help veterinary practices optimise inventory and reduce product waste.
- PropofolVet Multidose is indicated for anesthesia induction in dogs, maintenance of general anesthesia through intermittent bolus injections for short procedures, and induction when maintenance is provided with inhalant anesthetics. Both presentations offer a 28-day in-use shelf life without refrigeration.
- The 50 mL presentation strengthens Parnell’s anesthesia and sedation portfolio, which includes dexmedetomidine hydrochloride injection, CONTRASED (atipamezole hydrochloride), isoflurane, and sevoflurane. PropofolVet Multidose is now available in 50 mL (one per carton) and 20 mL (five per carton) formats.
Why It Matters?
Parnell’s 50 mL PropofolVet Multidose should help veterinary practices match vial size to procedure volume, cutting waste and improving inventory efficiency while keeping the same propofol use cases and 28-day, no-refrigeration convenience.
Marketwise, the new presentation deepens Parnell’s anesthesia franchise by giving clinics more flexibility in how they stock a first-generic propofol option, which can support broader adoption and cross-selling across the company’s sedation stack, including dexmedetomidine, CONTRASED, isoflurane and sevoflurane.
Source: Businesswire
